The rise and fall of 23andMe

businessinsider.com/timeline-the-rise-and-fall-of-23andme-2024-10

23andMe announced a reverse stock split in October.
Smith Collection/Gado
A class action lawsuit, resignations, and layoffs plagued 23andMe, which filed for Chapter 11 in March.
Biotech company Regeneron is buying the DNA testing startup's assets for $256 million.
Here's a look at the…

This story appeared on businessinsider.com, 2025-05-19 15:38:09.
The Entire Business World on a Single Page. Free to Use →